Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1075 of 1143 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/14
End: 01/04/22
Due: 01/04/23
Phase: N/A
Priority: Normal
Start: 12/22/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 09/08/17
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 09/18/18
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 05/10/18
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 01/11/18
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 10/15/18
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 04/17/19
Due: 04/17/20
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 05/16/17
End: 12/14/18
Due: 12/14/19
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/01/12
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 04/03/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 06/30/22
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 11/01/21
Due: 11/01/22
Phase: N/A
Priority: Normal
Start: 07/14/20
End: 09/30/21
Due: 09/30/22
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 12/31/04
Due: 12/31/05
Phase: N/A
Priority: Normal
Start: 11/01/16
End: 03/30/18
Due: 03/30/19
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 05/01/16
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/30/22
Due: 12/30/23